BlackRock’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $4.8M | Sell |
|
|||||
|
2022
Q2 | $8.5M | Sell |
|
|||||
|
2022
Q1 | $20.2M | Buy |
|
|||||
|
2021
Q4 | $26.4M | Buy |
|
|||||
|
2021
Q3 | $42.3M | Buy |
|
|||||
|
2021
Q2 | $51.1M | Buy |
|
|||||
|
2021
Q1 | $54.9M | Buy |
|
|||||
|
2020
Q4 | $32.9M | Buy |
|
|||||
|
2020
Q3 | $34.7M | Buy |
|
|||||
|
2020
Q2 | $38M | Buy |
|
|||||
|
2020
Q1 | $24.1M | Buy |
|
|||||
|
2019
Q4 | $35.6M | Sell |
|
|||||
|
2019
Q3 | $19.2M | Buy |
|
|||||
|
2019
Q2 | $67.6M | Buy |
|
|||||
|
2019
Q1 | $106M | Sell |
|
|||||
|
2018
Q4 | $78.1M | Buy |
|
|||||
|
2018
Q3 | $127M | Sell |
|
|||||
|
2018
Q2 | $197M | Buy |
|
|||||
|
2018
Q1 | $199M | Buy |
|
|||||
|
2017
Q4 | $253M | Buy |
|
|||||
|
2017
Q3 | $296M | Buy |
|
|||||
|
2017
Q2 | $318M | Buy |
|
|||||
|
2017
Q1 | $194M | Buy |
|
|||||
|
2016
Q4 | $114K | Sell |
|
|||||
|
2016
Q3 | $103K | Buy |
|
|||||
|
2016
Q2 | $35K | Buy |
|
|||||
|
2016
Q1 | $35K | Buy |
|
|||||
|
2015
Q4 | $29K | Sell |
|
|||||
|
2015
Q3 | $80K | Buy |
|
|||||
|
2015
Q2 | $56K | Sell |
|
|||||
|
2015
Q1 | $49K | Sell |
|
|||||
|
2014
Q4 | $42K | Hold |
|
|||||
|
2014
Q3 | $34K | Hold |
|
|||||
|
2014
Q2 | $32K | Buy |
|
|||||
|
2014
Q1 | $45K | Buy |
|
|||||
|
2013
Q4 | $36K | Buy |
|
|||||
|
2013
Q3 | $34K | Sell |
|
|||||
|
2013
Q2 | $184K | Buy |
|